AbbVie to acquire Allergan for $63bn
Mark Van Scyoc / Shutterstock.com
A group of senators has urged the US Federal Trade Commission (FTC) to closely scrutinise mergers in the pharmaceutical industry, which it said “increase competition issues and stifle innovation”.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
AbbVie, Allergan, US Federal Trade Commission, mergers and acquisitions, Amy Klobucher